Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms. by Williams, A. R. et al.
Br. J. Cancer (1985), 687-693
Immunohistochemical detection of the ras oncogene p21
product in an experimental tumour and in human colorectal
neoplasms
A.R.W. Williams', J. Piris1, D.A. Spandidos2'3 & A.H. Wyllie'
1Department ofPathology, Edinburgh University Medical School, Teviot Place, Edinburgh EH8 9AG;
2Beatson Institutefor Cancer Research, Garscube Estate, Switchback Road, Bearsden, Glasgow G6J IBD, UK
and 3Hellenic Institut Pasteur, Athens, Greece.
Summary The monoclonal antibody Y13 259 to the ras oncogene protein product p21 was used in an
immunohistochemical study of ras expression in human colorectal neoplasms. The ability of the antibody to
detect enhanced levels of ras expression was confirmed by its use with an experimental neoplasm known to
express ras at high levels. Human colonic adenocarcinomas in general showed a similar staining intensity to
that seen in normal mucosa. Adenomas however showed consistently high p21 expression as indicated by
staining intensity. This suggests that elevated ras expression may be important in the development of
adenomas, but that high levels need not be sustained in the conversion to invasive carcinoma.
Although the ras gene family has been studied
longer than any other group of cellular oncogenes,
there is still uncertainty over its role in authentic
human carcinogenesis. Ras genes code for GTP-
binding and GTP'ase enzyme activities of molecular
weight 21,000 daltons, referred to as p21 (Shih et
al., 1979; Gibbs et al., 1984; McGrath et al., 1984;
Sweet et al., 1984), which appear to be located on
the inner face of the plasma membrane (Willingham
et al., 1980), and are probably normally involved in
the transduction of membrane-associated stimuli for
cell proliferation (Bishop, 1983; Kamata &
Feramisco, 1984). Activation of the genes by
mutation has been detected in approximately 15%
of a wide variety of spontaneous human tumours
and transformed cell lines in culture (Der et al.,
1982; Parada et al., 1982; Pulciani et al., 1982;
Varmus, 1984). Raised levels of ras transcript have
also been identified in RNA extracted from several
types of human tumour (Spandidos & Kerr, 1984;
Slamon et al., 1984; Spandidos & Agnantis, 1984;
Spandidos et al., 1985). Controversy remains,
however, over whether ras activation is a primary
event in carcinogenesis or appears during tumour
progression. At a more pragmatic level, it is quite
obscure whether the detection of ras expression in
pre-malignant lesions or malignant tumours would
provide useful diagnostic or prognostic information.
In this paper, we describe the use of the mono-
clonal antibody Y13 259 in detection of ras p21 in
human colorectal neoplasms. We have confirmed
the ability of the antibody to detect enhanced levels
of ras expression by applying it in parallel to the
experimental neoplasm FHO5TI, in which high
levels of ras were achieved through genetic
manipulation.
Materials and methods
Tissues
Tissues used included 21 adenocarcinomas of the
colon and rectum, 6 benign tubular adenomas of
the colon, and 7 specimens of colonic tissue
resected for non-neoplastic conditions (diverticular
disease or ulcerative colitis). The diagnosis in each
case was confirmed on paraffin sections. Specimens
were received fresh within minutes of resection in
the operating theatre. They were examined
immediately, samples of tissue taken (including
where possible the tumour/normal interface), placed
in plastic vials and 'snap' frozen in liquid nitrogen
where they were stored until required. Frozen
sections (6 pm) were cut, mounted on gelatine-
coated slides, fixed in acetone at room temperature
for 15min and air dried. As controls for immuno-
staining, two cell lines were maintained in culture as
previously described (Spandidos & Wilkie, 1984):
the transformed line FHO5T1, which contains the
mutated T24 human Ha-ras oncogene inserted
within a high expression vector, and its parental,
untransformed Chinese hamster lung fibroblast
strain, here called CHL. FHO5T1 cells were also
grown as tumours in nude mice. Frozen sections of
these tumours and normal mouse tissues were
prepared exactly as above. The cultured cells were
studied in cytocentrifuge preparations, or in frozen
sections of pellets in low melting temperature
agarose, fixed as above.
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Antibodies
The monoclonal antibody to p21 designated Y13
259 was prepared from the hybridoma cell lines as
previously described (Furth et al., 1982). Secondary
antisera used in a comparison of reagents and
staining methods were horseradish-peroxidase
(HRP)-conjugated rabbit anti-rat Ig (Dako), HRP-
conjugated sheep anti-rat Ig (Amersham), biotin-
conjugated rabbit anti-rat IgG (Vector), un-
conjugated rabbit anti-rat Ig and monoclonal
peroxidase-anti-peroxidase complex (Sera Lab.).
Immunostaining
Sections were washed in TRIS-buffered saline,
pH7.6 (TBS) and non-specific binding blocked by
application of normal human serum diluted 1 in 5
in TBS (NHS/TBS). Y13 259 diluted 1 in 100 in
NHS/TBS was applied for 1 h. After washing in
TBS and blocking as above, the appropriate
secondary antibody was applied at a dilution of 1 in
50 in NHS/TBS for 1 h. Anti-human tissue activity
was significantly diminished in secondary antibodies
by absorption with acetone-dried human liver tissue
and human immunoglobulins (Cohn fraction II,
Sigma). Sections treated with HRP-conjugated
secondary antibodies were washed in TBS and the
reaction developed with DAB solution (1mgml-'
diaminobenzidine (BDH) in 50mM TRIS-HCl
pH 7.60, containing 10mM imidazole, activated
with H202 immediately prior to use. Sections
incubated with biotinylated secondary antisera were
washed in TBS and further incubated for 30min
with biotinylated preformed complex of
streptavidin-HRP (Amersham) diluted 1 in 200 in
TBS. After final washing, the reaction was
developed as above. Negative control sections were
included for each case, and positive controls
(cytocentrifuge preparations of the FHO5T1 cell
line) were used in each staining experiment.
Preliminary work comparing the indirect, PAP
and streptavidin-biotin methods showed highest
sensitivity with the latter method. In our hands, the
staining shown with Y13 259 in human tissues is
generally of relatively low intensity, and it is thus
important to minimise non-specific background
staining. The clear backgrounds and higher
dilutions of primary antibody afforded by the
amplified streptavidin-biotin method determined the
choice of this method in the main study.
Results
Experimental neoplasm
The transformed cell line FHO5T1 showed strong
reactivity of all cells with Y13 259, both in cyto-
centrifuge preparations and in frozen sections of cell
pellets. In contrast, the great majority of cells of the
parental strain from which it was derived (untrans-
formed Chinese hamster lung fibroblasts, termed
CHL), showed no reactivity. A small proportion
however, approximately 5%, showed strong specific
staining (Figures 1 and 2).
FHO5T1 cells inoculated into nude mice pro-
duced malignant tumours of fibrosarcomatous
appearance (to be described in detail elsewhere).
Frozen sections of such tumours showed strong
specific staining of all tumour cells with Y13 259,
whilst the adjacent murine tissues were negative
(Figure 3).
The reactivity of Y13 259 with this tumour was
completely lost in formalin-fixed paraffin-embedded
sections, and was not restored in any measure
by trypsinisation. Similarly, formaldehyde or
glutaraldehyde fixation of cytocentrifuge prepara-
tions of the FHO5T1 cell line abolished anti-
body binding. Y13 259 is therefore not suitable for
use with routinely processed biopsy material.
Human colonic tissues
Positive staining of the intensity of the FHO5T1
tumour was not seen in any of the human colonic
tissues studied. In general, where positive staining
was detected, it was of low intensity, despite use of
the most sensitive peroxidase detection system
available to us.
The results of staining of 21 colo-rectal adeno-
carcinomas, 6 colonic adenomas, their adjacent
uninvolved mucosa where available and 7 cases
of colonic resections for non-neoplastic conditions
are shown in Table I. Staining of sections was
independently assessed by two observers and
graded as equivocal or negative (+/-); moderate
Table I Staining intensity ofcolonic tissues for Y13 259.
Number ofcases -
staining intensity
Tissue +/- + + +
Carcinomas 15 4 2
Adenomas 0 1 5
Normal adjacent
to carcinoma 7 9 0
Normal adjacent
to adenoma 2 4 0
Normal non-neoplastic 4 3 0
Adenomas show a significantly greater intensity of
staining compared to carcinomas (P<0.01) and all
normals (P<0.002). (Four-fold Table Test). Carcinomas
show no significant difference in staining intensity from
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Figure 2 Parental untransformed Chinese hamster
Figure 1 Transformed (FHO5T1) cells - cyto- lung fibroblasts (CHL) stained with Y13 259. Most
centrifuge preparation. All cells show intensely positive cells show no reactivity, but a small subpopulation
staining with Y13 259. ( x 320). show intensely positive staining. ( x 320).
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Figure 3 Frozen section of advancing edge of FHO5T1 tumour in nude mouse. Tumour shows uniformly
intense staining (arrow); adjacent fibrous tissue and skeletal muscle (S) is negative. ( x 320).690 A.R.W. WILLIAMS et al.
(+) or intense (+ +). Agreement between observers
occurred in more than 75% of cases; where different
assessments were made, such cases did not affect
the statistical significance of the results. The Table
represents a consensus.
Normal colonic mucosa showed equivocal or
faintly positive reactivity of uniform distribution
with Y13 259 (Figure 4). No significant difference
was observed in the mucosa adjacent to neoplastic
lesions compared with mucosa from non-neoplastic
resections. Adenocarcinomas showed a variable
staining pattern; in 15, staining was absent or
equivocal, whilst 4 showed moderately strong
staining and 2 were graded as intense (Figure 5).
There was no correlation with the histological
pattern, depth of invasion or clinical stage of the
tumour. Where a difference was observed in
staining pattern between the carcinomas and the
adjacent mucosa, a sharp transition was not
observed. In contrast, 5 out of 6 colonic adenomas
showed intensely positive staining (Figure 6). The
interface between normal and neoplastic epithelium
in the adenomatous lesions did not show a sharp
Figure 5 Adenocarcinoma of colon showing positive
staining. (This case shows the most intense degree of
staining; the majority of carcinomas are negative).
( x 160)
Figure 4 Normal colonic mucosa shows only very
faint staining. (Macrophages in the lamina propria
show endogenous peroxidase activity). (x 160)
transition in reactivity; positive staining was often
most intense at the centre of the adenomas.
Discussion
The monoclonal antibody Y13 259 is one of a
series produced in rats bearing tumours induced by
the Harvey murine sarcoma virus (Furth et al.,
1982). These authors showed it to precipitate p21
protein species encoded by both the Harvey and
Kirsten strains of the virus. Ther?e is close
homology of the protein products of viral and
cellular ras genes. Capon et al. (1983a) have shown
the viral and cellular p21 protein products to be
identical in all but three out of 189 amino acid
residues. Y13 259, traced on immunoblots by the
streptavidin-biotin method, binds to a single protein
band, with an apparent mol.wt of 21,000 on SDS-
PAGE, present in substantial quantities in ras-
transformed cells, and at much lower levels inras p21 EXPRESSION IN HUMAN COLORECTAL TUMOURS
Figure 6 Tubular adenoma of colon showing intense staining with Y13 259. (x 160)
untransformed cells (D.A. Spandidos and T.
Dimitrov, unpublished work). The antibody is thus
potentially useful in the detection of c-ras oncogene
expression in human tissues.
It was of great value in this study to have access
to a known positive control in the form of the
experimental neoplasm FHO5T1. This transformed
cell line is known to express the mutated T24 Ha-
ras oncogene at high levels; quantitation of
oncogene mRNA in dot blots indicated 20-60 fold
more Ha-ras message in the transformed cells
relative to the untransformed parental fibroblasts
(Spandidos & Wilkie, 1984). Whilst there is no
formal proof of the specificity of Y13 259 for ras
p21, we have established its greatly increased
reactivity with ras-transformed cells over their
untransformed parental cell strain.
Although increased transcription of activated ras
genes has been observed in certain neoplasms
(DeFeo et al., 1981; Chang et al., 1982; McCoy et
al., 1983), mutation at specific positions (12 or 61)
in the amino acid coding sequence is the feature
most consistently observed in ras activation (Capon
et al., 1983a;b). It was therefore not surprising to
find that p21 expression in human tumours never
attained the artificially high levels seen in the
experimental tumour.
The presence of a subpopulation of CHL cells
strongly positive with Y13 259 may be related to
differential expression of ras at different stages in
the cell cycle (Campisi et al., 1984). It is less likely
to represent contamination of CHL by FHO5T1 or
spontaneous transformation of CHL cells, as the
proportion of ras positive CHL cells has not
changed after further passage in continuous culture.
The principal result of this study is the
consistently high level of p21 expression in
adenomas, whereas the carcinomas in general
showed lower staining intensity. As the great
majority of colo-rectal carcinomas are believed to
arise from adenomatous polyps (Morson &
Dawson, 1979), it would seem that the elevated p21
expression diminishes significantly as the lesions
evolve into invasive carcinomas.
An essentially similar conclusion was reached by
Spandidos and Kerr (1984), who reported increased
levels of RNA transcripts of Ki-ras and Ha-ras
oncogenes in a series of colonic adenomas and
adenocarcinomas, but noted higher expression of
ras mRNA in some adenomas compared with
corresponding carcinomas from the same patients.
A recent study employing the same antibody Y13
259 with immunoblotting techniques (Gallick et al.,
1985) also reached the conclusion that p21
expression tended to be greatest in the earlier stages
ofcolonic carcinomas.
The p21 proteins are thought to function as
transducers of signals from the extracellular
environment to the nucleus in a system intimately
involved in the control of cellular proliferation
(Hurley et al., 1984; Kamata and Feramisco, 1984).
Activation, even by mutation, of ras appears to
result in the delivery of a continuous signal rather
than a regulated one (Sweet et al., 1984). Ras
activation may be an early event in the develop-
ment of adenomas, which are known to show a
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shorter cell cycle time as well as expansion of the
proliferating compartment relative to the normal
mucosa (Bleiberg & Galand, 1976; Deschner &
Lipkin, 1976). Indeed, cycle times in adenomas are
shorter than those of carcinomas. A further
carcinogenic stimulus or stimuli may be required
for conversion of adenomas to invasive carcinomas,
with sustained elevations of ras expression perhaps
being no longer necessary. An analogous situation
of early ras activation has been described in the
context of chemical skin carcinogenesis in mice,
where c-Ha-ras has been found to be activated at
the stage of benign papilloma formation (Balmain
et al., 1984).
The findings of this study differ significantly
from those described by Thor et al. (1984), who
found ras p21 expression to correlate with the
depth of invasion of colonic carcinoma within the
bowel wall. Using different monoclonal antibodies
raised to synthetic peptides reflecting part of the
p21 protein structure, they found p21 expression in
normal colonic mucosa and colonic adenomas to be
negative or very low, whilst carcinomas expressed
relatively high levels. This was interpreted as indi-
cating ras activation to be a late stage in the
development of colonic malignancy. The reasons
for this discrepancy are not clear, but the different
methods used in raising these antibodies suggest
they may have very different specificities from Y13
259.
It would be of great interest to determine
whether the elevated p21 expression detected in
adenomas is a product of the normal cellular
oncogene, or of the activated mutated gene. The
monoclonal antibodies currently available are
unable to distinguish between the mutated p21
protein and the normal, but analysis of restriction
fragment polymorphism of DNA extracted from
tumours may be a more promising approach. Work
is currently proceeding in our laboratory to address
this question.
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